RxDoctor Payments Data

Matthew Hubbard, MD

Otolaryngology/Facial Plastic Surgery · Abingdon, VANPI 1700100286

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,067 of the $2,769 with a category attached, or 74.7%. 17 manufacturers reported payments, led by Stryker at 50.9% of the total. Reporting peaked in 2022 at $1,407 and has fallen 85.8% since, to $199 in 2025.

$2,769in general payments, 2019–2025

Across 69 payments — averaging $40.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$1K
  • GSK$476
  • Sanofi$172
  • Musculoskeletal Transplant Foundation Inc.$141
  • Regeneron Healthcare Solutions, Inc.$131
  • Inspire Medical Systems, Inc.$111
  • plus $331 from 11 others

What the payments were for

  • Travel & lodging$70225%
  • Food & beverage$2,06775%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few otolaryngology/facial plastic surgery providers in Virginiato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$364,210
Medicare patients
885
Services billed
17,436

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide98$2,397
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth13$1,434
Fluticasone Propionate96$1,225
Ofloxacin22$737
Montelukast Sodium47$415
Famotidine33$360
Mupirocin29$334
Prednisone27$253
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav17$223
Omeprazole15$184
Ciprofloxacin Hcl17$160
Levothyroxine Sodium18$90

Paid to pharmacies, not to this prescriber.

Other otolaryngology/facial plastic surgery in Abingdon

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →